Share buybacks · 2021–2022
Ironwood Pharmaceuticals share buybacks
$126M+423.8% · FY2022
Ironwood Pharmaceuticals (IRWD) reported $126M in share buybacks for fiscal 2022, +423.8% year on year.
Share buybacks — Share buybacks are the cash a company spent during the year repurchasing its own stock, taken from the financing section of the cash-flow statement. Most companies buy back nothing at all — the line is absent rather than zero — so this ranking covers the minority that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2021–2022 compound annual growth +423.8%
Share buybacks at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ironwood Pharmaceuticals share buybacks |url=https://companiesranked.com/en/company/ironwood-pharmaceuticals/share-buybacks |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ironwood Pharmaceuticals share buybacks. CompaniesRanked. https://companiesranked.com/en/company/ironwood-pharmaceuticals/share-buybacksBibTeX
@misc{companiesranked-en-company-ironwood-pharmaceuticals-share-buybacks-2026,
author = {{CompaniesRanked}},
title = {{Ironwood Pharmaceuticals share buybacks}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ironwood-pharmaceuticals/share-buybacks}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.